Figure 1 (Sotalol Fig1)
Sotalol Hydrochloride Tablet
Product Images NDC 59651-775
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Sotalol Hydrochloride (NDC 59651-775). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1: Study 1 (Sotalol Fig2)
Figure 2: Study 2 (Sotalol Fig3)
Package Label-principal Display Panel (80 mg (100 Tablets Bottle))
Package Label-principal Display Panel (120 mg (100 Tablets Bottle))
Package Label-principal Display Panel (160 mg (100 Tablets Bottle))
This is a description for Sotalol HCI tablets, USP (AF). Each tablet contains 160 mg of Sotalol hydrochloride. This medication is distributed by Aurobindo Pharma USA, Inc. The tablets should be dispensed in a tight, light-resistant container with a child-resistant closure. The medication should be stored at 20° to 25°C (68° to 77°F). Please refer to the accompanying prescribing information for the usual dosage. The packaging includes GTIN, Serial Number, Expiry Date, LOT, and Coding Area.*
Chemical Structure (Sotalol Str)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
